Usage of radiopharmaceuticals in the development of pharmaceutical drug delivery systems: Validation of [99mTc]DTPA and [99mTc]ECD

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 57, Issue 2, 2004, Pages 347-352

  Terán, Mariella ^a   Savio, Eduardo ^a   Paolino, Andrea ^a   Frier, Malcolm ^b  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Drug delivery; Pharmaceutical development; Radiopharmaceuticals; Tablet formulation; Validation; 99mTc DTPA; 99mTc ECD

Indexed keywords

CINARIZINE; CYSTEINE ETHYL ESTER TC 99M; DRUG CARRIER; PENTETIC ACID; PLACEBO; RADIOPHARMACEUTICAL AGENT; RANITIDINE; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG;

ACIDITY; ALKALINITY; ARTICLE; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG USE; EXPERIMENTAL TEST; KINETICS; LIPOPHILICITY; RADIOACTIVITY; SCINTIGRAPHY; SCINTILLATION CAMERA; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; TECHNIQUE; WET DEPOSITION;

EID: 1442286227     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2003.11.003     Document Type: Article

References (22)

1. Perkins A., Frier M. Nuclear Medicine in Pharmaceutical Research. 1999;Taylor & Francis, London. pp. 71-112.
2. Bean H.S. Advances in Pharmaceutical Sciences. 1992;Academic Press, London. pp. 154-162.
3. Martini L.G., Embleton J.K., Malcolmson R.J., Wilson C.G. The use of small volume ocular sprays to improve the bioavailability of topically applied ophthalmic drugs. Eur. J. Biopharm. 44:(2):2003;121-126.
4. x) in healthy subjects. Eur. J. Nucl. Med. 26:(4):1999;320-327.
5. Davies S.S., Hardy J.G., Newman S.P., Wilding I.R. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms (Review article). Eur. J. Nucl. Med. 19:1992;971-986.
6. O. Kosch, Magnetic markers in gastroenterology, Bioelect Biomagnet, http://www.berlin.ptbde/8/82/821/gastroe.htm.
7. Wilson C.G., Mc Jury M., O'Mahoy B., Frier M., Perkins A.C. Imaging of oily formulations in the gastrointestinal tract. Adv. Drug Deliv. Rev. 25:1997;91-101.
8. Wilson C.G., Bakhashaee M., Stevens N.N.E. An evaluation of gastro-resistant pulsed release delivery system (Pulsincap) in man. J. Drug Deliv. 5:1997;201-206.
9. Perkins A.C., Frier M. Nuclear medicine techniques in the evaluation of pharmaceutical formulations. Pharm. World Sci. 18:1996;97-104.
10. Dams T.M., Cortens H. Lessons for medicine and nuclear medicine research (Editorial). Eur. J. Nucl. Med. 26:1999;311-313.
11. Perkins A.C., Mann C., Wilson C.G. Three dimensional visualisation of the large bowel: a potential tool for assessing targeted drug delivery and colonic pathology. Eur. J. Nucl. Med. 22:1995;1035-1038.
12. Newman S.P., Wilding I.R. Imaging techniques for assessing drug delivery in man. Pharm. Sci. Technol. Today. 2:1999;181-189.
13. Perkins A.C. Oesophageal transit, disintegration and gastric empting of a film-coated resindronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects. Aliment Pharmacol. Ther. 15:2001;115-121.
14. Perkins A.C., Wilson C.G., Frier M., Vincent R.M., Blackshaw P.E., Dansereau R.J., Juhlin K.D., Bekker P.J., Spiller R.C. Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations. Int. J. Pharm. 186:1999;169-175.
15. Jurisson S., Berning D., Jia W., Dangshe M. Coordination compounds in nuclear medicine. Chem. Rev. 93:(3):1993;1137-1156.
16. Terán M., Paolino A., Savio E., Gaudiano J.P., León A.S., Frier M. Centellografía en el desarrollo farmacéutico: estudios in vitro e in vivo de comprimidos de ranitidina. Acta Farmacéutica Bonaerense. 19:(3):2000;217-224.
17. Burns H.D., Gibson E.R., Dannals R., Siegl P.K. Nuclear Imaging in Drug Discovery, Development and Approval. 1993;Birkhäuser, Boston. pp. 301-318.
18. C.G. Wilson, Use of imaging techniques to interpret variability in drug delivery, Drug Delivery Supplement, http://www.pharmabrieffing.com/ businessbrieffing/pdf/pharmatech2001/reference/reference16.pdf.
19. Wilding I.R. Using product visualization techniques to characterize dosage form performance in man. British Pharmaceutical Conference, 2001. Abstract Book: 306. 2001.
20. Cid Cárcamo E. Control de calidad biofarmacéutico de Medicamentos. 1992;Ed. Baigraf, Chile. pp. 60-112.
21. ARCAL XV. Manual de protocolos de calidad de radiofármacos. 1999;OIEA, Japan. pp. 39-52.
22. Smith D.L. Statistics and Data Uncertainties in Nuclear Science and Technology. vol. 4:1991;American Nuclear Society, LaGrange Park, IL. pp. 178-230.